We demonstrated that the HPV vaccine can indirectly promote NK-cell immunity via IL-15 DC, illustrated by phenotypic NK-cell activation and synergistically increased cytotoxicity against HPV16+ and HPV18+ cervical cancer cells by Cer-DC/NK-cell co-cultures. This evidence concerns the gene IL15 and cervical carcinoma.